News

This common parasite causes birth defects — but the US doesn’t screen for it during pregnancy

Bill Sullivan
Sept. 1, 2024

Imagine the shock of your baby being born with a swollen brain, blindness and debilitating seizures. Now imagine learning that these devastating conditions could have been prevented if you took a simple test for the common parasite Toxoplasma gondii.

Toxoplasma can be picked up anywhere an infected cat has defecated, such as the litter box, sandbox, garden or yard. Other routes of infection include consumption of contaminated water, undercooked meat or shellfish. Most people experience mild illness and can get the infection under control.

Toxoplasma gondii is a single-celled parasite.
Toxoplasma gondii is a single-celled parasite.

However, if contracted for the first time while pregnant, Toxoplasma can cross the placenta and cause spontaneous abortion or serious birth abnormalities. Such mother-to-child transmission during pregnancy is called congenital toxoplasmosis. Up to 4,400 babies may be born with congenital toxoplasmosis in the U.S. each year.

As professor of microbiology at the Indiana University School of Medicine, I study the biology of Toxoplasma in my lab. Blood tests can monitor the amount of Toxoplasma antibodies in the parent. Increases indicate an acute infection is taking place, putting the fetus at risk of congenital toxoplasmosis. However, promptly administering anti-parasitic drugs to pregnant people who develop toxoplasmosis can help protect the fetus from the worst outcomes of congenital toxoplasmosis.

Several nations, such as France and Austria, have been testing and treating toxoplasmosis during pregnancy for decades. Brazil recently started a similar program.

However, Toxoplasma testing is not included in prenatal screening in the U.S.

Why screen for toxoplasmosis during pregnancy?

Toxoplasma is a widespread and stealthy infection. Over 40 million American adults are infected with the parasite, underscoring how easy it is to catch. And since the infection usually doesn’t cause overt symptoms, many mothers of infected babies cannot recall when or how they became infected.

Studies conducted in multiple countries have demonstrated the benefits of detecting and treating toxoplasmosis during pregnancy.

Some countries, such as France, have implemented routine prenatal toxoplasmosis screening and treatment.
Some countries, such as France, have implemented routine prenatal toxoplasmosis screening and treatment.

The first randomized clinical trial assessing the efficacy and safety of a treatment to reduce toxoplasmosis transmission prenatally, Toxogest, published its findings in 2018. Although the trial was halted due to lack of funding, results suggested that treatment not only reduced infection transmission, but also decreased disease severity for breakthrough infections.

A meta-analysis of 33 studies published from 2017 to 2021 also found that pregnant women given the antibiotic spiramycin also showed significantly lower rates of parasite transmission to their unborn child compared with untreated mothers.

For Jose Montoya, a toxoplasmosis researcher and clinician at the Remington Laboratory at Sutter Health, the value of screening is clear. “In countries that perform prenatal screening for toxoplasmosis, the severity of congenital toxoplasmosis is far less than what is routinely observed in the U.S.,” he said.

Congenital toxoplasmosis may be more common than believed

Some have argued that congenital toxoplasmosis is too rare to warrant prenatal testing. But the U.S. currently screens for conditions that are even rarer than toxoplasmosis, such as phenylketonuria.

The incidence of congenital toxoplasmosis may also be underestimated. Currently, there are no national surveillance data on toxoplasmosis available, as it is not a nationally notifiable disease in the U.S. Since most states do not monitor or report this infection during pregnancy, researchers don’t know how many miscarriages are caused by Toxoplasma or how many children suffer from the infection.

A 2021 report by the Centers for Disease Control and Prevention highlighted the shortcomings of toxoplasmosis surveillance in the U.S., stating that routine, standardized testing during pregnancy would provide crucial data to evaluate the scope of this threat to babies. Additionally, it would inform researchers on the causes of the high rate of stillbirths in the U.S., which disproportionately affect Black women.

A pregnant person can transmit toxoplasmosis to their developing baby.

Some researchers have warned that Toxoplasma prevalence may rise with the popularity of free-range, organically raised foods and climate change. Free-range animals are more prone to pick up infectious Toxoplasma oocysts in outdoor pastures and water sources, which have a higher likelihood of being contaminated with cat feces. Warmer temperatures and more powerful storms due to climate change promote oocyst persistence and dissemination in the environment – for example, through increased soil erosion polluting waterways.

Additionally, reports of unusually virulent Toxoplasma strains migrating from South America may exacerbate the severity of congenital toxoplasmosis infections in the U.S.

Costs of toxoplasmosis during pregnancy

“This disease not only has a steep physical and emotional cost, but also an important economic one,” said Rima McLeod, director of the Toxoplasmosis Center at the University of Chicago.

A study McLeod conducted in 2011 estimated that following France’s prenatal screening and treatment model could save U.S. taxpayers US$620 per child, or $2.5 billion annually.

Researchers have also developed new technologies that reduce concerns about the testing costs.

McLeod’s team developed an inexpensive finger-prick test that detects Toxoplasma within 30 minutes. Other researchers have also developed a saliva-based test.

How to avoid toxoplasmosis

Avoiding litter duty while pregnant can help protect you from toxoplasmosis.
Avoiding litter duty while pregnant can help protect you from toxoplasmosis.

Toxoplasma produces significant, lifelong neurological and vision impairments in hundreds of babies born in the U.S. each year. Congenital toxoplasmosis can be largely mitigated with prenatal testing and treatment protocols that are safe and easy to perform.

“Those who conducted the Toxogest clinical trial did not incorporate a placebo control because it was deemed unethical not to monitor and treat congenital toxoplasmosis,” Montoya said. “But currently, pregnant people in the U.S. are being relegated into such a placebo group – denied simple, low-cost procedures that could save their children from birth defects.”

Without systematic prenatal testing for congenital toxoplasmosis, the best that pregnant people can do is become vigilant to the risk factors. Those who are pregnant should avoid cleaning the litter box and other areas where cats may have defecated. Fruits and vegetables should be washed before consuming. Meat products should be cooked to proper temperature.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

The Conversation

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Bill Sullivan

Bill Sullivan is a professor at Indiana University School of Medicine and the author of several books.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Proteomic variation in heart tissues
Journal News

Proteomic variation in heart tissues

June 17, 2025

By tracking protein changes in stem cell–derived heart cells, researchers from Cedars-Sinai uncovered surprising diversity — including a potential new cell type — that could reshape how we study and treat heart disease.

Parsing plant pigment pathways
Webinar

Parsing plant pigment pathways

June 13, 2025

Erich Grotewold of Michigan State University, an ASBMB Breakthroughs speaker, discusses his work on the genetic regulation of flavonoid biosynthesis.

Calcium channel linked to cancer drug resistance
Journal News

Calcium channel linked to cancer drug resistance

June 12, 2025

Researchers discover a protein associated with carboplatin-resistant retinoblastoma, suggesting this protein could be a promising therapeutic target. Read more about this recent Journal of Biological Chemistry paper.

Host fatty acids enhance dengue virus infectivity
Journal News

Host fatty acids enhance dengue virus infectivity

June 12, 2025

Researchers in Germany find that viral replication depends on host enzymes that synthesize lipids, revealing potential metabolic targets for antiviral intervention. Read more about this recent Journal of Biological Chemistry paper.

Antibodies inhibit hyperactive protein disposal
Journal News

Antibodies inhibit hyperactive protein disposal

June 12, 2025

Researchers at the University of California, San Francisco, identify an enzyme inhibitor, offering new tools to study diseases like cystic fibrosis, neurodegeneration and cancer. Read more about this recent Journal of Biological Chemistry paper.

Scientists find unexpected correlation between age and HDL-C levels
Journal News

Scientists find unexpected correlation between age and HDL-C levels

June 3, 2025

In a 30-year multicenter study, researchers determined what factors predict HDL-C concentration. In their analysis, they found that HDL-C levels grew with increasing age and physical activity.